Mammary Neoplasms, Experimental
"Mammary Neoplasms, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
| Descriptor ID |
D008325
|
| MeSH Number(s) |
C04.588.531.500 C04.619.590 E05.598.500.496.843
|
| Concept/Terms |
Mammary Neoplasms, Experimental- Mammary Neoplasms, Experimental
- Experimental Mammary Neoplasm
- Mammary Neoplasm, Experimental
- Neoplasm, Experimental Mammary
- Neoplasms, Experimental Mammary
- Experimental Mammary Neoplasms
|
Below are MeSH descriptors whose meaning is more general than "Mammary Neoplasms, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Mammary Neoplasms, Experimental".
This graph shows the total number of publications written about "Mammary Neoplasms, Experimental" by people in this website by year, and whether "Mammary Neoplasms, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 7 | 2 | 9 |
| 2018 | 3 | 2 | 5 |
| 2019 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Mammary Neoplasms, Experimental" by people in Profiles.
-
A small cytotoxic peptide from frog elicits potent antitumor immunity to prevent local tumor growth and metastases. Future Med Chem. 2019 10; 11(19):2505-2525.
-
A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling. Cell Chem Biol. 2019 08 15; 26(8):1143-1158.e6.
-
Endothelial miR-30c suppresses tumor growth via inhibition of TGF-ß-induced Serpine1. J Clin Invest. 2019 03 11; 129(4):1654-1670.
-
Beyond the Roles in Biomimetic Chemistry: An Insight into the Intrinsic Catalytic Activity of an Enzyme for Tumor-Selective Phototheranostics. ACS Nano. 2018 12 26; 12(12):12169-12180.
-
PEGylated BF2-Azadipyrromethene (NIR-AZA) fluorophores, for intraoperative imaging. Eur J Med Chem. 2019 Jan 01; 161:343-353.
-
Targeting intracellular MMPs efficiently inhibits tumor metastasis and angiogenesis. Theranostics. 2018; 8(10):2830-2845.
-
Lysosome-Independent Intracellular Drug/Gene Codelivery by Lipoprotein-Derived Nanovector for Synergistic Apoptosis-Inducing Cancer-Targeted Therapy. Biomacromolecules. 2018 02 12; 19(2):438-448.
-
Characterizing viscoelastic properties of breast cancer tissue in a mouse model using indentation. J Biomech. 2018 03 01; 69:81-89.
-
In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors. Genes Chromosomes Cancer. 2018 04; 57(4):182-191.
-
Marine fish oil is more potent than plant-based n-3 polyunsaturated fatty acids in the prevention of mammary tumors. J Nutr Biochem. 2018 05; 55:41-52.